DPIIT recognised startup Government of India
Startup India
Antila Generic Medicine Private Limited - pharma in Bardez, Goa, India. Directors, charges & compliance details.
Revenue · FY 2024
₹5.81 Cr
▲ 84% YoY
Net profit · FY 2024
₹39.16 Lakh
Net margin 6.7%
EBITDA · FY 2024
₹63.24 Lakh
EBITDA margin 10.9%
Authorised capital
₹90,000
Registered with MCA
Paid-up capital
₹90,000
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Antila Generic Medicine Private Limited
Data last updated:
Antila Generic Medicine Private Limited is a private limited company based in Bardez, Goa, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U85300GA2021PTC014700.
The company has an authorised share capital of ₹90,000 and a paid-up capital of ₹90,000. It is led by directors Shubhangi Parshuram Naik and Anushka Parshuram Naik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.409 4th Floor Fortune Square Building Morod, Bardez, Goa, India – 403507.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.81 Cr, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹39.16 Lakh (net margin 6.7%) and EBITDA of ₹63.24 Lakh (EBITDA margin 10.9%).
The company is associated with 1 brand: Antila Generic Medicine. As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Antila Generic Medicine Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GA-01-0009877). For more details, the company can be reached via its website antila.in.
Company details
CIN U85300GA2021PTC014700
Registration Number 014700
Incorporation Date 23 February 2021
ROC Goa
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GA-01-0009877
Recognitions & Rankings of Antila Generic Medicine
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-GA-01-0009877
Contact details
Antila Generic Medicine Private Limited's registered office is in Bardez, Goa.
- Registered AddressOffice No.409 4th Floor Fortune Square Building Morod, Bardez, Goa, India – 403507
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Antila Generic Medicine Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Antila Generic Medicine operates one associated brand: Antila Generic Medicine. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distribution of generic and branded medicines, along with OTC products, in India. | antila.in |
Business activity
The main business activity of Antila Generic Medicine is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Antila Generic Medicine Private Limited, buy the company report.
Financials of Antila Generic Medicine Private Limited
FY 2025 filings availableAntila Generic Medicine Private Limited reported revenue of ₹5.81 Cr (up 84% YoY) for FY 2024.
Revenue · FY 2024
₹5.81 Cr ▲ 84%
Net profit · FY 2024
₹39.16 Lakh margin 6.7%
EBITDA · FY 2024
₹63.24 Lakh margin 10.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 84%
EBITDA CAGR growth
1 year
▲ 669%
Revenue rose 84% in the latest year. EBITDA rose 669% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹63.24 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹39.16 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 10.9% | |||
| Net Profit Margin | 6.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Antila Generic Medicine Private Limited, buy the company report.
Board of directors of Antila Generic Medicine Private Limited
Antila Generic Medicine has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubhangi Parshuram Naik | Director | 23 Feb 2021 | 5 Years 8 Months | Current |
| Anushka Parshuram Naik | Director | 27 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Antila Generic Medicine Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Green-Watt Techno Solutions Private Limited | ₹5.81 Cr (FY 2019) | -8.0% | Gurgaon, Haryana, India | |||
| Neoarc Exim Private Limited | ₹5.81 Cr (FY 2024) | -28.0% | Rajkot, Gujarat, India | |||
| Aquinnova Healthcare Private Limited | ₹5.81 Cr (FY 2024) | 25.0% | Bhiwandi, Maharashtra, India | |||
| Kortera Foods Private Limited | ₹5.81 Cr (FY 2025) | 1630.0% | Mumbai, Maharashtra, India | |||
| Maryus Healthcare Private Limited | ₹5.81 Cr (FY 2025) | -36.0% | Mumbai, Maharashtra, India | |||
| Antila Generic Medicine Private Limitedthis company | ₹5.81 Cr (FY 2024) | ₹39.16 Lakh | 6.7% | 84.0% | Bardez, Goa, India | |
| Alicante Surfaces Private Limited | ₹5.81 Cr (FY 2024) | -62.0% | Mumbai, Maharashtra, India | |||
| Argent Finvest Private Limited | ₹5.81 Cr (FY 2023) | New Delhi, Delhi, India | ||||
| Patel Auto Service Mall Private Limited | ₹5.8 Cr (FY 2025) | 34.0% | Mumbai, Maharashtra, India | |||
| R S Castings Private Limited | ₹5.8 Cr (FY 2024) | -23.0% | Haryana, India | |||
| Next Gen Pharma India Private Limited | ₹5.8 Cr (FY 2023) | -30.0% | Delhi, India |
To see the full peer comparison of Antila Generic Medicine Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101084818 | Hdfc Bank Limited | ₹1.5 Cr | Open |
To see the full charge records of Antila Generic Medicine Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Antila Generic Medicine Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Cadila Pharmaceuticals Ltd and 1 other | Pending |
To see the full case history of Antila Generic Medicine Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Antila Generic Medicine Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Antila Generic Medicine Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Antila Generic Medicine Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Anushka Parshuram Naik ceased to be Additional Director on 01 Mar 2023.
AGM
Antila Generic Medicine Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 15,000,000.00 registered on 27 Mar 2025 with Charge ID 101084818 was modified on 17 Jun 2025.
Filing
Antila Generic Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15,000,000.00 with Charge ID 101084818 was registered on 27 Mar 2025.
Ceased
Anushka Parshuram Naik ceased to be Additional Director.
Ceased
Lochana Bennalkar ceased to be Director.
Appointed
Anushka Parshuram Naik was appointed as Director.
Appointed
Shubhangi Parshuram Naik was appointed as Director.
Incorporation
23 Feb 2021
Antila Generic Medicine Private Limited was registered on 23 Feb 2021 with Roc Goa & aged 5 years 8 months as per MCA records.
Frequently asked questions
Antila Generic Medicine is an active private limited company based in Bardez, Goa, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 February 2021 (5+ years old) and is registered under CIN U85300GA2021PTC014700.
Antila Generic Medicine has 2 current directors:
- Shubhangi Parshuram Naik - Director
- Anushka Parshuram Naik - Director
The latest financial statements of Antila Generic Medicine on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Antila Generic Medicine is U85300GA2021PTC014700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antila Generic Medicine has 1 court case on record: 1 filed against it. 1 is pending.
Antila Generic Medicine was incorporated on 23 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Antila Generic Medicine by revenue are Green-Watt Techno Solutions Private Limited, Neoarc Exim Private Limited, Aquinnova Healthcare Private Limited, Kortera Foods Private Limited, Maryus Healthcare Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anushka Parshuram Naik ceased to be Additional Director on 01 Mar 2023. Lochana Bennalkar ceased to be Director on 28 Sep 2022. Anushka Parshuram Naik was appointed as Director on 27 Sep 2022. Antila Generic Medicine has 4 board changes on record in total.
Yes, Antila Generic Medicine is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Antila Generic Medicine is registered as a micro enterprise under Udyam registration (number: UDYAM-GA-01-0009877).
Antila Generic Medicine can be reached through the website antila.in. Its registered office is in Bardez, Goa, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages